Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03753256

Evaluation of Optical Coherence Tomography in Dentistry

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Heidelberg Medical Center · Academic / Other
Sex
All
Age
6 Years
Healthy volunteers
Not accepted

Summary

Optical coherence tomography (OCT) is a medical diagnostic tool, providing non-invasive, non-radiative and high resolution imaging. OCT has been established since many years in ophthalmology. In dentistry the diagnostic potential of OCT is currently increasingly being noticed. This clinical study includes two individual trials: (i) Longitudinal assessment of surface sealant thickness using optical coherence tomography and (ii) comparison of crevicular fluid levels of inflammatory cytokines after the application of surface sealants.

Detailed description

Trial 1: Evaluation of the abrasion behavior of the orthodontic surface sealants Pro Seal®, Opal®Seal, and Protecto®CaF2Nano. The quadrants of 20 participants will be randomly assigned to four study groups. Using a split mouth design three commonly used orthodontic surface sealants (Pro Seal®, Opal®Seal, and Protecto®CaF2Nano) and a bonding primer (Transbond XT) which is used as a control will be applied to the labial surfaces of the teeth of the respective quadrants. The thickness changes of the orthodontic surface sealants and the development of enamel demineralization will be monitored at the day of the application and five additional time points (t1= 1 month, t2= 3 months, t3= 6 months, t4=9 months, t5= 12 months) using OCT. Trial 2: Evaluation of Adverse effects of orthodontic surface sealants. 15 quadrants of the trial group described above (Trial1) will be randomly selected and gingival crevicular fluid (GCF) will be sampled in the respective quadrants at the day of bracket bonding prior (t0) and at three additional time points (t1= 30 min, t2= 60 min, t3= 90 min) after the application of surface sealants or the bonding primer, respectively. Analysis will be performed using magnetic Luminex screening assays for IL-8 (Interleukin 8), and IL-10 (Interleukin 10) and examined for inflammatory cytokines after the application of surface sealants.

Conditions

Interventions

TypeNameDescription
DEVICETransbond XTApplication of • Transbond XT (activator comparator) to labial surfaces of teeth of randomized quadrants.
DEVICEProtecto®CaF2NanoApplication of • Protecto®CaF2Nano (orthodontic surface sealant) to labial surfaces of teeth of randomized quadrants.
DEVICEPro Seal®Application of • Protecto®CaF2Nano (orthodontic surface sealant) to labial surfaces of teeth of randomized quadrants.
DEVICEOpal®SealApplication of • Opal®Seal (orthodontic surface sealant) to labial surfaces of teeth of randomized quadrants.

Timeline

Start date
2017-12-04
Primary completion
2019-08-01
Completion
2027-12-01
First posted
2018-11-26
Last updated
2018-11-28

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03753256. Inclusion in this directory is not an endorsement.